These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24694254)

  • 21. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF tau markers are correlated with hippocampal volume in Alzheimer's disease.
    de Souza LC; Chupin M; Lamari F; Jardel C; Leclercq D; Colliot O; Lehéricy S; Dubois B; Sarazin M
    Neurobiol Aging; 2012 Jul; 33(7):1253-7. PubMed ID: 21489655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain.
    Alcolea D; Martínez-Lage P; Izagirre A; Clerigué M; Carmona-Iragui M; Alvarez RM; Fortea J; Balasa M; Morenas-Rodríguez E; Lladó A; Grau O; Blennow K; Lleó A; Molinuevo JL
    J Alzheimers Dis; 2014; 39(4):719-26. PubMed ID: 24254700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid retrieval in the conscious dog: a methods development study.
    Rockar RA; Sandanaga KK; Burkett DE; Mitroka JG; Bonner RA; Weinstein MJ
    J Invest Surg; 1995; 8(1):85-94. PubMed ID: 7734435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An alternative method of chronic cerebrospinal fluid collection via the cisterna magna in conscious rhesus monkeys.
    Gilberto DB; Zeoli AH; Szczerba PJ; Gehret JR; Holahan MA; Sitko GR; Johnson CA; Cook JJ; Motzel SL
    Contemp Top Lab Anim Sci; 2003 Jul; 42(4):53-9. PubMed ID: 12906404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.
    Johansson P; Mattsson N; Hansson O; Wallin A; Johansson JO; Andreasson U; Zetterberg H; Blennow K; Svensson J
    J Alzheimers Dis; 2011; 24(3):537-46. PubMed ID: 21297262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of cerebrospinal fluid flow through the olfactory system may contribute to Alzheimer's disease pathogenesis.
    Ethell DW
    J Alzheimers Dis; 2014; 41(4):1021-30. PubMed ID: 24769627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary.
    Hampel H; Elhage A; Shaw LM; Aisen P; Chen C; Lleó A; Iwatsubo T; Iwata A; Yamada M; Ikeuchi T; Jia J; Wang H; Teunissen CE; Peskind E; Blennow K; Cummings J; Vergallo A
    Neurodegener Dis Manag; 2022 Oct; 12(5):221-229. PubMed ID: 35866715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal Catheterization and Drug Delivery in Guinea Pigs: A Small-animal Model for Morphine-evoked Granuloma Formation.
    Eddinger KA; Rondon ES; Shubayev VI; Grafe MR; Scadeng M; Hildebrand KR; Page LM; Malkmus SA; Steinauer JJ; Yaksh TL
    Anesthesiology; 2016 Aug; 125(2):378-94. PubMed ID: 27272672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
    BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.
    Gordon BA; Friedrichsen K; Brier M; Blazey T; Su Y; Christensen J; Aldea P; McConathy J; Holtzman DM; Cairns NJ; Morris JC; Fagan AM; Ances BM; Benzinger TL
    Brain; 2016 Aug; 139(Pt 8):2249-60. PubMed ID: 27286736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
    Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
    JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
    Savage MJ; Holder DJ; Wu G; Kaplow J; Siuciak JA; Potter WZ;
    J Alzheimers Dis; 2015; 46(2):431-40. PubMed ID: 25790831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.
    Brandner S; Thaler C; Lelental N; Buchfelder M; Kleindienst A; Maler JM; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2014; 41(4):1057-62. PubMed ID: 24748118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).
    Vanderstichele H; Demeyer L; Janelidze S; Coart E; Stoops E; Mauroo K; Herbst V; François C; Hansson O
    Alzheimers Res Ther; 2017 Jun; 9(1):40. PubMed ID: 28587660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated pressure-controlled cerebrospinal fluid drainage during open thoracoabdominal aortic aneurysm repair.
    Tshomba Y; Leopardi M; Mascia D; Kahlberg A; Carozzo A; Magrin S; Melissano G; Chiesa R
    J Vasc Surg; 2017 Jul; 66(1):37-44. PubMed ID: 28216365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.